09/23/2024 3:15 PM | Munk Natalie (Reporting) Myriad Genetics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/23/2024 3:17 PM | Ancona Margaret (Reporting) Myriad Genetics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/23/2024 3:21 PM | Myriad Genetics (Issuer) Verratti Mark (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/16/2024 1:30 PM | Ancona Margaret (Reporting) Myriad Genetics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/12/2024 3:09 PM | Muzzey Dale (Reporting) Myriad Genetics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/12/2024 3:11 PM | DIAZ PAUL J (Reporting) Myriad Genetics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/11/2024 2:26 PM | Muzzey Dale (Reporting) Myriad Genetics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
|
09/11/2024 9:05 AM | DIAZ PAUL J (Reporting) Myriad Genetics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/09/2024 4:48 PM | Dreismann Heinrich (Reporting) Myriad Genetics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/09/2024 1:52 PM | Dreismann Heinrich (Reporting) Myriad Genetics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/04/2024 6:51 PM | Fox Jennifer Lynne (Reporting) Myriad Genetics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/04/2024 6:38 PM | Myriad Genetics (Issuer) Reitan Colleen F (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/03/2024 7:43 PM | Myriad Genetics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/03/2024 3:33 PM | Fox Jennifer Lynne (Reporting) Myriad Genetics (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
09/03/2024 9:11 AM | Myriad Genetics (Subject) Reitan Colleen F (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/26/2024 3:48 PM | Munk Natalie (Reporting) Myriad Genetics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/23/2024 3:16 PM | Ancona Margaret (Reporting) Myriad Genetics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/20/2024 3:38 PM | Kumar Rashmi (Reporting) Myriad Genetics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/19/2024 1:46 PM | Kumar Rashmi (Reporting) Myriad Genetics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/14/2024 3:27 PM | DIAZ PAUL J (Reporting) Myriad Genetics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/07/2024 7:22 AM | Myriad Genetics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
06/04/2024 4:57 PM | Myriad Genetics (Issuer) SPIEGELMAN DANIEL K (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/04/2024 9:32 AM | Myriad Genetics (Subject) SPIEGELMAN DANIEL K (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/03/2024 12:48 PM | Myriad Genetics (Subject) SPIEGELMAN DANIEL K (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/15/2024 4:48 PM | Myriad Genetics (Issuer) Newcomer Lee Nisley (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/15/2024 4:49 PM | DIAZ PAUL J (Reporting) Myriad Genetics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/15/2024 3:24 PM | DIAZ PAUL J (Reporting) Myriad Genetics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/13/2024 11:14 AM | Myriad Genetics (Subject) Newcomer Lee Nisley (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/08/2024 7:14 AM | Myriad Genetics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
04/17/2024 3:31 PM | Myriad Genetics (Filer)
| Form DEF 14A | |
04/17/2024 3:31 PM | Myriad Genetics (Filer)
| Form DEFA14A | |
04/17/2024 3:33 PM | Myriad Genetics (Filer)
| Form ARS | |
04/15/2024 3:25 PM | Myriad Genetics (Issuer) Verratti Mark (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/15/2024 3:27 PM | Muzzey Dale (Reporting) Myriad Genetics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/08/2024 3:49 PM | Munk Natalie (Reporting) Myriad Genetics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/18/2024 3:39 PM | MILLENNIUM MANAGEMENT LLC (Filed by) Myriad Genetics (Subject)
| Form SC 13G | |
03/04/2024 3:18 PM | Myriad Genetics (Issuer) Solaiman Shereen (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/28/2024 7:31 AM | Myriad Genetics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/14/2024 7:24 AM | Camber Capital Management LP (Filed by) Myriad Genetics (Subject)
| Form SC 13G/A | |
01/29/2024 3:21 PM | Leffler Scott J. (Reporting) Myriad Genetics (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
01/29/2024 3:27 PM | Leffler Scott J. (Reporting) Myriad Genetics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
Next opportunity for crypto millions (Ad) The floodgates have opened.
Bitcoin and Ethereum ETFs are seeing record-breaking inflows, the biggest since they first opened to investors. Wall Street is finally embracing crypto.
But most investors are missing the real goldmine…
Go here to discover the crypto that's about to leave Wall Street in the dust. |
01/24/2024 12:20 PM | Myriad Genetics (Subject) STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/23/2024 3:31 PM | INTEGRATED CORE STRATEGIES LLC (0001319244) (Filed by) Myriad Genetics (Subject)
| Form SC 13G/A | |
01/22/2024 1:03 PM | BlackRock Inc. (Filed by) Myriad Genetics (Subject)
| Form SC 13G/A | |
01/16/2024 8:00 AM | Myriad Genetics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/02/2024 4:52 PM | Muzzey Dale (Reporting) Myriad Genetics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/21/2023 7:30 AM | Myriad Genetics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/11/2023 5:34 PM | Myriad Genetics (Issuer) Raha Samraat S. (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
12/11/2023 5:41 PM | Myriad Genetics (Issuer) Raha Samraat S. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/05/2023 3:19 PM | Myriad Genetics (Issuer) Riggsbee Richard Bryan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/13/2023 3:31 PM | Myriad Genetics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/13/2023 5:02 AM | Myriad Genetics (Filer)
| Form 424B5 | |
11/08/2023 8:16 PM | Myriad Genetics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/07/2023 7:30 AM | Myriad Genetics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/06/2023 3:05 PM | Myriad Genetics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/03/2023 4:12 PM | Myriad Genetics (Issuer) Riggsbee Richard Bryan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/01/2023 8:00 PM | Myriad Genetics (Subject) Riggsbee Richard Bryan (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/01/2023 8:00 AM | Myriad Genetics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/31/2023 3:34 PM | Myriad Genetics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/19/2023 3:17 PM | Myriad Genetics (Issuer) Wong Pamela (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/17/2023 3:14 PM | INTEGRATED CORE STRATEGIES LLC (0001319244) (Filed by) Myriad Genetics (Subject)
| Form SC 13G | |
10/11/2023 8:00 AM | Myriad Genetics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/10/2023 3:15 PM | Muzzey Dale (Reporting) Myriad Genetics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/10/2023 3:17 PM | Haas Kevin Richard (Reporting) Myriad Genetics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/10/2023 3:19 PM | Lambert Nicole (Reporting) Myriad Genetics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/10/2023 3:21 PM | Myriad Genetics (Issuer) Verratti Mark (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/10/2023 3:22 PM | Myriad Genetics (Issuer) Riggsbee Richard Bryan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |